Finance

Beta
Lists
BWAY:NASDAQ
Brainsway Ltd - ADR
$14.04
-3.57%
(-0.52) 1D
$14.04
0.00% (0.00)
After hours
Closed: Jun 3, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BWAY...
Open
$14.06
High
$14.23
Low
$13.78
Mkt. cap
569.76M
Avg. vol.
143.77K
Volume
0.00
P/E ratio
37.28
52-wk high
$17.35
52-wk low
$5.04
EPS
$0.38
Beta
1.20
Shares outstanding
40.09M
No. of employees
129
Open
$14.06
High
$14.23
Low
$13.78
Mkt. cap
569.76M
Avg. vol.
143.77K
Volume
0.00
P/E ratio
37.28
52-wk high
$17.35
52-wk low
$5.04
EPS
$0.38
Beta
1.20
Shares outstanding
40.09M
No. of employees
129
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to BWAY in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for BWAY in the last 3 months.
Highest
Current $14.04
$17.00 (+21.08%)
Average
$17.00 (+21.08%)
Lowest
$17.00 (+21.08%)
News stories
From sources across the web
Profile
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
About Brainsway Ltd - ADR
CEOHadar Levy | Christopher von Jako
Employees129
Founded2003
HeadquartersJerusalem, Jerusalem District, Israel
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
12.63M
13.51M
14.54M
15.53M
Cost of goods sold
3.13M
3.35M
3.43M
3.86M
Cost of revenue
3.13M
3.35M
3.43M
3.86M
Research and development expenses
2.34M
2.40M
2.53M
2.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.58M
6.51M
6.67M
6.79M
Operating expense
8.92M
8.91M
9.20M
9.67M
Total operating expenses
12.05M
12.26M
12.63M
13.53M
Operating income
578.00K
1.25M
1.92M
2.00M
Other non operating income
-
-
2.52M
-
EBT including unusual items
2.10M
1.81M
2.54M
2.41M
EBT excluding unusual items
2.10M
1.81M
2.54M
2.41M
Income tax expense
70.00K
242.00K
-334.00K
120.00K
Effective tax rate
3.34%
13.38%
-13.14%
4.98%
Other operating expenses
-
-
-
-
Net income
2.03M
1.57M
2.88M
2.29M
Net profit margin
16.05%
11.59%
19.77%
14.74%
Earnings per share
0.02
0.02
0.06
0.06
Interest and investment income
2.14M
1.13M
216.00K
724.00K
Interest expense
-621.00K
-571.00K
-1.53M
-319.00K
Net interest expenses
1.52M
555.00K
-1.32M
405.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
966.00K
1.66M
2.27M
2.47M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more